Meet the Opening Speaker for SCbio 2025: John Crowley

The SCbio 2025 Annual Conference in Charleston Feb. 18-20 will begin with John Crowley, president and chief executive officer (CEO) of the Biotechnology Innovation Organization(BIO), the world’s largest biotechnology advocacy organization. Every year, South Carolina’s largest life sciences event opens with a keynote to remind industry professionals of the impact of their work.

Crowley’s involvement with biotechnology began in 1998 when two of his children were diagnosed with Pompe disease—a severe and often fatal neuromuscular disorder. In his search for a cure, Crowley left his position at Bristol Myers Squibb and became an entrepreneur as the co-founder, president and CEO of Novazyme Pharmaceuticals, a biotech start-up conducting research on a new experimental treatment for Pompe disease, which he credits with saving his children’s lives.

Crowley and his family have been profiled numerous times on the front page of The Wall Street Journal and are the subjects of a book by Pulitzer prize-winning journalist Geeta Anand, “The Cure: How a Father Raised $100 Million-And Bucked the Medical Establishment-In a Quest to Save His Children.” The 2010 major motion picture, Extraordinary Measures, starring Brendan Fraser, Harrison Ford and Keri Russell, is inspired by the Crowley family’s journey. He is also the author of a personal memoir: “Chasing Miracles: The Crowley Family Journey of Strength, Hope, and Joy.”

Crowley served as a commissioned officer in the U.S. Navy Reserve from 2005-2016 and is a veteran of the global war on terrorism, with service in Afghanistan. He attended the U.S. Naval Academy and earned a Bachelor of Science in Foreign Service from Georgetown University, a Juris Doctor from the University of Notre Dame Law School and a Masters of Business Administration from Harvard Business School.

The Crowley family received the 2011 Family Exemplar Award from the University of Notre Dame. He is also a member of the University Council on Science and Technology at the institution and serves on the Board of Directors of the U.S. Naval Academy Foundation. Crowley is the former national chairman of the Make-A-Wish Foundation of America, served on the board of BioNJ and is a Henry Crown Fellow at the Aspen Institute. In 2020, he delivered the commencement address for the University of Notre Dame’s graduating class and was awarded a Doctor of Laws degree, receiving honoris causa. In 2023, Crowley was inducted as a member of the Horatio Alger Association.

The SCbio Annual Conference stands as the premier life sciences event in the Southeast, where global leaders and industry experts exchange insights, form powerful connections and discover exciting new achievements from the fastest-growing economic sector in South Carolina. Additionally, SCbio will unveil its new initiative aimed at defining the core pillars of the state’s life sciences and medtech sectors to attract companies to the state—highlighting the organization’s commitment to fostering innovation and growth in these critical sectors.

Visit  https://cvent.me/mB12w1 to register and view sponsorship opportunities for the SCbio Annual Conference.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.